ChipMonk's GLP-1 Boosting Cookies are formulated with fiber-rich, functional ingredients to enhance feelings of fullness and keep snackers' cravings in check.
Unlike the average cookie, these from ChipMonk are inspired by the latest GLP-1 science and note some of the most common GLP-1 suppressors, like refined sugars and carbs. These GLP-1 cookies launched in classic varieties like Chocolate Chip Pecan and Chocolate Chip Protein, as well as a Chocolate Chip Protein Dairy-Free, which are low in carbs, gluten-free and diabetic-friendly thanks to ingredients like almond flower, monk fruit and stevia leaf extract. Featuring a proprietary blend of prebiotic fibers, these cookies are not only nourishing to the gut but also useful for supporting steady energy as blood sugar dips, providing lasting satiety, and encouraging weight management via improved appetite control.
GLP-1-Boosting Cookies
ChipMonk's Cookies Increase Fullness with Protein and Prebiotic Fibers
Trend Themes
-
Functional Snackification — Snacks are being reformulated to deliver clinically relevant physiological effects like prolonged satiety and glycemic stability, creating space for bite-sized products that compete with traditional meal replacements.
-
Microbiome-targeted Foods — Prebiotic- and fiber-forward formulations are being designed to selectively modulate gut microbes and metabolic signaling, enabling consumables that influence appetite and energy regulation through the microbiome.
-
GLP-1 Nutritional Positioning — Nutritional products are increasingly marketed around their capacity to support incretin pathways such as GLP-1, allowing nonpharmaceutical offerings to sit alongside weight-management and metabolic therapies.
Industry Implications
-
Nutrition and Packaged Foods — CPG brands have an opportunity to launch clinically informed SKUs that trade on metabolic outcomes rather than indulgence, reshaping category growth toward health-first treats.
-
Pharmaceuticals and Biotech — Adjunct nutritional products could be developed to complement or extend the efficacy of metabolic drugs, blurring lines between therapeutics and functional foods.
-
Food Retail and CPG Distribution — Retail channels may need new shelving and messaging strategies to accommodate hybrid products that require consumer education about metabolic benefits and glycemic-friendly positioning.